Development of advanced gastric cancer treated with weekly administration of paclitaxel
- VernacularTitle:单周方案紫杉醇单药治疗在晚期胃癌应用的进展
- Author:
Qiang CHEN
;
Xiaofeng LI
- Publication Type:Journal Article
- Keywords:
advanced gastric cancer;
chemotherapy;
paclitaxel
- From:China Oncology
2006;0(10):-
- CountryChina
- Language:Chinese
-
Abstract:
Benefits in survival and quality of life have been demonstrated in patients with advanced gastric cancer receiving chemotherapy plus optimal supportive care versus optimal supportive care alone.The taxanes, which are among the most promising cytotoxic agents in clinical use have considerable activity in a number of tumor types.Paclitaxel,especially low-dose weekly administration,has shown encouraging activity in the treatment of advanced gastric cancer as a single agent.Patients treated with the low-dose weekly paclitaxel regimen had a statistically superior response rate and time to disease progression as well as clinically significant prolongation of survival.And it offers a new option for those advanced gastric patients such as the aged,poor performance status(PS) or unsuitable for combination chemotherapy,and those even with no indications for rountine chemotherapy.This review is focused on the clinical reports of low-dose weekly administration of paclitaxel for patients with advanced gastric cancer.
